Ranitidine is often referred to as Zantac, and is available in various forms, including tablet, injection, and effervescent tablet preparations. This drug helps to prevent and treat gastric-acid associated conditions, including ulcers, because of its ability to decrease gastric acid secretion. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ranitidina, Ranitidinum, Zantac and Gavilast. Its PubChem CID is 3001055.
Ranitidine
| CAS No | 66357-35-5 |
|---|---|
| Molecular Formula | C13H22N4O3S |
| Molecular Weight | 314.41 g/mol |
| Synonyms | (E)-1-N‘-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ranitidine is often referred to as Zantac, and is available in various forms, including tablet, injection, and effervescent tablet preparations. This drug helps to prevent and treat gastric-acid associated conditions, including ulcers, because of its ability to decrease gastric acid secretion.
The listed CAS number is 66357-35-5.
The listed molecular formula is C13H22N4O3S.
The listed molecular weight is 314.41 g/mol.
(E)-1-N‘-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine.
The source lists Ranitidina, Ranitidinum, Zantac and Gavilast.